You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
10 April 2024
AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock
8 September 2023
Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update
1 February 2023
Adrenomed appoints Dr. Stephan Witte as Chief Medical Officer
12 July 2022
Adrenomed appoints David Germonpré as Chief Financial Officer
23 June 2022
Adrenomed appoints Dr. med. Steffen Stürzebecher as Chief Medical Officer
11 April 2022
PEI Regulatory Approval Received for Government Funded Clinical Trial Investigating Adrenomed’s Adrecizumab in Treating Endothelial Barrier Dysfunction in Hospitalized COVID-19 Patients